AI Article Synopsis

  • PSMA-positive exosomes could be used as highly sensitive biomarkers for detecting prostate cancer, leading to early diagnosis.
  • A novel electrochemical biosensor was developed that employs PSMA-specific peptides to capture and signal these exosomes using silver nanoparticles, allowing for precise measurement of exosome concentration.
  • The biosensor demonstrated an impressive detection range and limit, and it performed well with clinical samples, highlighting its potential for real-world applications in prostate cancer detection.

Article Abstract

Prostate specific membrane antigen (PSMA)-positive exosomes have the potential to serve as highly sensitive biomarkers for prostate cancer detection. Herein, a sensitive electrochemical biosensor for the ultrasensitive detection of PSMA-positive exosomes has been constructed based on a peptide-templated AgNPs nanoprobe. In this work, PSMA-specific binding peptides immobilized on a gold electrode were responsible for prostate cancer-derived exosomes capturing. Well-designed peptide (CCY- LWYIKC) serves a dual role: as a signal probe and as a recognizer in the exosomes-identification process. Specifically, LWYIKC bind to cholesterol at the exosome membranes, and CCY function as peptide templates to host a large number of silver nanoparticles, leading to a strong electrochemical signal. Thus, the concentration of exosomes can be quantified via electrochemical signal. This innovative method displayed a wide detection range of 10 to 10 particles/μL and a detection limit as low as 37 particles/μL. Notably, the method has shown outstanding performance when validated using clinical samples, suggesting its potential for clinical applications.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bios.2022.114978DOI Listing

Publication Analysis

Top Keywords

peptide-templated agnps
8
agnps nanoprobe
8
prostate cancer
8
psma-positive exosomes
8
electrochemical signal
8
novel peptide-templated
4
nanoprobe theranostics
4
prostate
4
theranostics prostate
4
cancer prostate
4

Similar Publications

Article Synopsis
  • PSMA-positive exosomes could be used as highly sensitive biomarkers for detecting prostate cancer, leading to early diagnosis.
  • A novel electrochemical biosensor was developed that employs PSMA-specific peptides to capture and signal these exosomes using silver nanoparticles, allowing for precise measurement of exosome concentration.
  • The biosensor demonstrated an impressive detection range and limit, and it performed well with clinical samples, highlighting its potential for real-world applications in prostate cancer detection.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!